Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 2016

View Archived Issues

ZIOPHARM plans phase I study of CD33 CAR T-cell therapy

MJFF, van Andel Research and Cure Parkinson's Trust to study nilotinib in Parkinson's disease

IntelGenx starts phase I trial of montelukast for the treatment of neurodegenerative diseases

Oncodesign launches phase 0/I trial for ODS-2004436 radiotracer

Mutations in TRMT10C identified as a cause of mitochondrial disease

Aptinyx starts dosing in phase I trial for NYX-2925

Merck & Co. patents BTK inhibitors

OncoArendi Therapeutics describes arginase inhibitors

King's College London discloses retinoid RARbeta receptor agonists

Revlimid approved in Europe for relapsed or refractory MCL

Hitgen reports HDAC inhibitors

NovoBiotic Pharmaceuticals receives grant from NIAID to advance teixobactin program

Dethree Res, J-Pharma and Nippon Chemiphar present URAT1 inhibitors

Update on U.S. regulatory filing for Raxone in Duchenne muscular dystrophy

Juno Therapeutics acquires RedoxTherapies

Boehringer Ingelheim announces collaboration with the University of Dundee

Three organizations merge to form Lupus Research Alliance

ArmaGen presents data on AGT-182 for Hunter syndrome

GSK exercises option under respiratory disease collaboration with Five Prime

Plex Pharmaceuticals obtains funding to develop compounds for Parkinson's disease

NTRK2 shows promise as a therapeutic target for astrocytoma

Disruption of TRIP8b-HCN interaction may induce antidepressant-like behavior

Tyrosine kinase inhibitor shows promise in Parkinson's disease patients

FDA advisory committee recommends approval of biosimilar etanercept

New panel shows promise for infection diagnosis

An RYR1 mutation is associated with bleeding abnormalities

NIH expands investment to advance basic medical research toward HIV cure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...